Literature DB >> 20842334

[The importance of depressive syndromes for incipient Alzheimer-type dementia in advanced age].

M A Rapp1, R Hellweg, A Heinz.   

Abstract

Based on epidemiological data on the risk for dementia conveyed by depression, we report recent findings on the effects of depressive disorders on cognition in later life and its relationship to incipient Alzheimer's disease. We review the current literature on possible mechanisms underlying the depression-dementia association. The findings summarized in this review underline the central importance of depressive disorders for the diagnosis and treatment of psychiatric disorders in later life.

Entities:  

Mesh：

Year:  2011        PMID： 20842334     DOI： 10.1007/s00115-010-3129-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


  32 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

2.  Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

Authors:  Robert C Green; L Adrienne Cupples; Alex Kurz; Sanford Auerbach; Rodney Go; Dessa Sadovnick; Ranjan Duara; Walter A Kukull; Helena Chui; Timi Edeki; Patrick A Griffith; Robert P Friedland; David Bachman; Lindsay Farrer
Journal:  Arch Neurol       Date:  2003-05

3.  Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment.

Authors:  Rainer Hellweg; Peter Lohmann; Roman Huber; Alexander Kühl; Matthias W Riepe
Journal:  Learn Mem       Date:  2006-01-17       Impact factor: 2.460

4.  Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion.

Authors:  R M Nitsch; M Deng; J H Growdon; R J Wurtman
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

Review 5.  Definitions and distinctions among depressive syndromes and symptoms: implications for a better understanding of the depression-cardiovascular disease association.

Authors:  Karina W Davidson; Nina Rieckmann; Michael A Rapp
Journal:  Psychosom Med       Date:  2005 May-Jun       Impact factor: 4.312

6.  Neuropsychological differences between late-onset and recurrent geriatric major depression.

Authors:  Michael A Rapp; Karen Dahlman; Mary Sano; Hillel T Grossman; Vahram Haroutunian; Jack M Gorman
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

7.  Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Authors:  Constantine G Lyketsos; Lourdes DelCampo; Martin Steinberg; Quincy Miles; Cynthia D Steele; Cynthia Munro; Alva S Baker; Jeannie-Marie E Sheppard; Constantine Frangakis; Jason Brandt; Peter V Rabins
Journal:  Arch Gen Psychiatry       Date:  2003-07

8.  A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.

Authors:  A L Nyth; C G Gottfries; K Lyby; L Smedegaard-Andersen; J Gylding-Sabroe; M Kristensen; H E Refsum; E Ofsti; S Eriksson; S Syversen
Journal:  Acta Psychiatr Scand       Date:  1992-08       Impact factor: 6.392

9.  Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease?

Authors:  Enrico Mossello; Marta Boncinelli; Veronica Caleri; Maria Chiara Cavallini; Eliana Palermo; Mauro Di Bari; Sabrina Tilli; Eva Sarcone; David Simoni; Carlo Adriano Biagini; Giulio Masotti; Niccolò Marchionni
Journal:  Dement Geriatr Cogn Disord       Date:  2008-03-20       Impact factor: 2.959

10.  Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration.

Authors:  Sandra Bell-McGinty; Meryl A Butters; Carolyn Cidis Meltzer; Phil J Greer; Charles F Reynolds; James T Becker
Journal:  Am J Psychiatry       Date:  2002-08       Impact factor: 18.112
View more
  1 in total

1.  Linking late life depression and Alzheimer's disease: mechanisms and resilience.

Authors:  Sara L Weisenbach; Joseph Kim; Dustin Hammers; Kelly Konopacki; Vincent Koppelmans
Journal:  Curr Behav Neurosci Rep       Date:  2019-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.